Akebia Therapeutics Q3'26 Earnings Preview
Akebia Therapeutics is scheduled to report Q3'26 results on October 29; the release time is unspecified. EPS is anticipated at $(0.04).
Akebia Therapeutics is scheduled to report Q3'26 results on October 29; the release time is unspecified. EPS is anticipated at $(0.04).